CNW/ -- (SSE: 603087) today announced that two pivotal phase 3 clinical trials, SUPER-1 and SUPER-2, evaluating ...

A large study found many diabetic individuals who self-administer insulin are incorrectly injecting the treatment, prompting experts to create formal recommendations, Reuters reported. Of the 13,289 ...

Insulin icodec, a once-weekly basal injection to treat type 1 diabetes, has the potential to be as effective in managing the condition as daily basal insulin treatments, according to research from the ...

(1,2) "Awiqli (R) is an important new option that meets a real need as the first FDA-approved, once-weekly basal insulin for adult patients with type 2 diabetes. It's helping to reframe what basal ...

For over a century, scientists have chased the dream of insulin pills, but the digestive system kept destroying the drug ...

“Insulin injections remain a daily burden for many patients,” said Shingo Ito, an associate professor at Kumamoto University ...

Most diabetes patients must carefully monitor their blood sugar levels and inject insulin multiple times per day, to help ...

If youre on insulin to treat type 1 or type 2 diabetes, its critical to know exactly how to use it. Insulin can be a very dangerous drug if used improperly, says Stanley Mathew, MD, an endocrinologist ...

Findings from 16-week trial of novel compression patch will be shared for the first time at the 85 th Scientific Sessions of the American Diabetes Association, beginning today "The findings from this ...

Awiqli® (insulin icodec-abae) injection is the first-ever once-weekly basal insulin approved by the FDAAwiqli® offers adults ...